Gilead forms pact with Car­tog­ra­phy to map new tar­gets for can­cer drugs

Gilead will work with fel­low Cal­i­for­nia biotech Car­tog­ra­phy Bio­sciences to find new tar­gets for breast and lung can­cer med­i­cines, the com­pa­nies said Tues­day morn­ing. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER